VAMP2 | Vesicle-associated membrane protein 2 (synaptobrevin 2) | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
VGF | VGF nerve growth factor inducible | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ARRB1 | Arrestin, beta 1 | Predicted intracellular proteins
| | | | | Expressed in all |
CPE | Carboxypeptidase E | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DENND4C | DENN/MADD domain containing 4C | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DOK5 | Docking protein 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
GHR | Growth hormone receptor | Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
GNAS | GNAS complex locus | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GPR119 | G protein-coupled receptor 119 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HNF1B | HNF1 homeobox B | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
HTRA4 | HtrA serine peptidase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
IGFL1 | IGF-like family member 1 | Predicted secreted proteins
| | | | | Tissue enriched |
IGFL3 | IGF-like family member 3 | Predicted secreted proteins
| | | | | Tissue enriched |
IGFL4 | IGF-like family member 4 | Predicted intracellular proteins
| | | | | Tissue enriched |
INSM2 | Insulinoma-associated 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PDK4 | Pyruvate dehydrogenase kinase, isozyme 4 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
PTRF | Polymerase I and transcript release factor | Disease related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
RAB10 | RAB10, member RAS oncogene family | Predicted intracellular proteins
| | | | | Expressed in all |
RAB13 | RAB13, member RAS oncogene family | Predicted intracellular proteins
| | | | | Expressed in all |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SOCS1 | Suppressor of cytokine signaling 1 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
YWHAG | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AACS | Acetoacetyl-CoA synthetase | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AANAT | Aralkylamine N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ACSL6 | Acyl-CoA synthetase long-chain family member 6 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ACVR2B | Activin A receptor, type IIB | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADM | Adrenomedullin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AGMO | Alkylglycerol monooxygenase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AGPAT2 | 1-acylglycerol-3-phosphate O-acyltransferase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGRP | Agouti related neuropeptide | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AKAP5 | A kinase (PRKA) anchor protein 5 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ANGPTL4 | Angiopoietin-like 4 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANKRD26 | Ankyrin repeat domain 26 | Predicted intracellular proteins
| | | | | Mixed |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
AP3S1 | Adaptor-related protein complex 3, sigma 1 subunit | Predicted intracellular proteins
| | | | | Expressed in all |
APLN | Apelin | Predicted intracellular proteins
| | | | | Tissue enhanced |
APOBEC1 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 | Predicted intracellular proteins
| | | | | Group enriched |
APRT | Adenine phosphoribosyltransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ARNTL | Aryl hydrocarbon receptor nuclear translocator-like | Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP6V0A2 | ATPase, H+ transporting, lysosomal V0 subunit a2 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |